Outset Medical, Inc.

Outset Medical, Inc.

Outset Medical, Inc.

Overview
Date Founded

2012

Headquarters

1830 Bering Drive,San Jose, CA 95112

Type of Company

Private

Industries

Hospitals & Patient Services
Holding Companies

Company Description

Outset Medical, Inc. provides dialysis solutions to patients and healthcare providers. It Tablo reduces the time consumed in setting up and managing dialysis, whether at home or in clinic. The company wads founded on March 05, 2012 and is headquartered in Sunnyvale, CA.

Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Chief Medical Officer

Senior Vice President, Operations & Engineering

Vice President, Quality & Regulatory Operations

Corporate Vice President, Global Devices R&D, Hospira

Vice President-Commercial & Corporate Strategy

Vice President, Manufacturing & Customer Service

Vice President, Software, Analytics & Mobile

Board of Directors

Former President, Chief Executive Officer & Director at Thoratec Corp.

Managing Director, Healthcare & Consumer at Warburg Pincus LLC

Corporate Vice President, Global Devices R&D, Hospira at Outset Medical, Inc.

Managing Director at Warburg Pincus LLC

Director at Cardiovascular Systems, Inc.

President & Chief Executive Officer at Outset Medical, Inc.

Paths to Outset Medical, Inc.
Potential Connections via
Relationship Science
You
Outset Medical, Inc.
Recent Transactions
Details Hidden

Outset Medical, Inc. raised money in a private placement transaction

Details Hidden

Outset Medical, Inc. raised money in a private placement transaction

Details Hidden

Outset Medical, Inc. raised money in a private placement transaction

Advisors & Consultants
Advisor

Nephrology Chief at Stanford Health Care

Advisor

Former Director-Clinical Research at Denver Nephrologists PC

Advisor

Former President at The Canadian Society of Nephrology

Investors
Details Hidden

Fidelity Management & Research Co.'s (FMR) investment approach is based on a rigorous, fundamental, bottom-up stock selection process. The firm seeks to identify and invest in the stocks of companies with the potential for long-term capital appreciation or companies with hidden or unrealized value.FMR uses a wide variety of investment strategies in managing client assets, including, but not limited to, investments in: stocks and other equity securities; stocks with growth or value characteristics; bonds and other debt securities and repurchase agreements for those securities; and real estate related investments. The firm may participate in short sales, margin transactions, and option writing, including covered options, uncovered options or spreading strategies. FMR invests in US and non-US issuers, including issuers in emerging or frontier markets. They invest in companies with small, medium and large market capitalizations. Investments are allocated across different asset classes, market sectors, maturities, countries, and regions. Investments may be made in the securities of companies engaged in particular industries or market sectors and in a combination of underlying Fidelity funds.Margin may be required in connection with certain client futures and options transactions or in connection with short sales. FMR does not engage in the purchase of securities on margin, except in connection with the clearance and settlement of securities transactions.FMR may engage in swap transactions and swaptions, including interest rate, total return and credit default; written covered call options; and futures transactions, currency spot and forward trading and other currency related derivatives. In addition, FMR may engage in securities lending to parties such as broker-dealers or other institutions.

Details Hidden

The Vertical Group focuses on the medical technology and biotechnology sectors. The Vertical Group's investment activities are not restricted by transaction type or company size. The firm manages private partnerships that participate in early-stage and angel financings, later-stage venture capital financings, buyouts of operating companies involved in a recapitalization or corporate spin-off and investments in public companies of all sizes. Investments range from $500,000 to $10 million in venture capital transactions, to over $25 million buyout or public stock transactions. The Vertical Group's private partnerships have an evergreen structure and over 50% of partnership capital is represented by the firm's four founding General Partners and two Special Limited Partners. Because of their evergreen structure, it is not uncommon for The Vertical Group to maintain investment positions for ten years or longer.

Details Hidden

Partner Fund Management (PFM) generally uses bottom-up analysis to identify trends, investment themes and core investment opportunities across asset classes and geographies in a wide range of investment instruments. The firm may invest in various industries or sectors, including, but not limited to, communications and media, consumer, energy, financials, healthcare, industrials, materials, technology and utilities. Their main investment strategies include diversified global and healthcare. PFM seeks to identify out- and under-performing companies that have the widest expectation gaps relative to consensus. In some cases, they may apply a catalyst-driven investment approach to express their fundamental view with respect to a company. PFM may also engage in top-down macro-economic analysis to identify opportunities, whether on a directional or relative value basis, across a wide range of global markets and investment instruments. They may consider economic, political and financial market conditions in seeking to identify attractive investment opportunities. The firm invests in and trades a wide range of investment instruments, including securities, options, ETFs, futures, currencies, derivatives, debt instruments and other assets that are financial instruments. They take both long and short positions in such investment instruments.